The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...

We currently know that COPD, and specifically emphysema, don’t just happen alongside lung cancer; they increase a person’s ...

BostonGene has entered a new collaboration with AstraZeneca to apply its foundation AI model to oncology drug development, aiming to improve early trial decision-making around safety, efficacy, and ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells ...

Belfast-based biotech company Biomarx has raised £700,000 in pre-seed funding to progress the development of a diagnostics ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells ...

Genmab is discontinuing development of acasunlimab after a pipeline review, pivoting focus to other oncology antibodies.

Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using genetically identical cells derived from stem cells taken from a single donor.The ...

Volastra Therapeutics, a clinical-stage biotechnology company pioneering first-in-class therapies targeting chromosomal ...

Background The relationship of social determinants of health (SDOH), environmental exposures and medical history to lung function trajectories is underexplored. A better understanding of these ...

A big new study, with researchers from Harvard and CREA, just uncovered something troubling about Delhi’s air: almost a third ...

For the first time, a breathing lung model has been made using cells from only one person. Announced on January 1, the ...